Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature (Q33502056)

27 July 2017

1 reference

title

Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature (English)

1 reference

metastatic colorectal carcinoma

27 July 2017

phase II clinical trial

0 references

1 reference

Tellez C

1

1 reference

27 July 2017

Benson AB 3rd

2

1 reference

27 July 2017

Lyster MT

3

1 reference

27 July 2017

Talamonti M

4

1 reference

27 July 2017

Shaw J

5

1 reference

27 July 2017

Braun MA

6

1 reference

27 July 2017

Nemcek AA Jr

7

1 reference

27 July 2017

Vogelzang RL

8

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

27 July 2017

1 reference

27 July 2017

82

1 reference

27 July 2017

7

1 reference

27 July 2017

1250-1259

1 reference

Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history

27 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Regional treatment of hepatic metastases and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

The carcinoid syndrome: palliation by hepatic artery embolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Islet cell tumors metastatic to the liver: effective palliation by sequential hepatic artery embolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Hepatic artery embolization in the treatment of hepatic neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Peripheral hepatic artery embolization for primary and secondary hepatic neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Regression of hepatic metastases from gastrointestinal leiomyosarcoma after hepatic arterial chemoembolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Gastrointestinal leiomyosarcoma metastatic to the liver. Durable tumor regression by hepatic chemoembolization infusion with cisplatin and vinblastine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Arterial chemoembolization with microencapsulated anticancer drug. An approach to selective cancer chemotherapy with sustained effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Hepatic artery infusion and chemoembolization in the management of liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Pharmacologic rationale for regional drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Arterial embolization in the management of liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Intraarterial infusion chemotherapy for metastatic liver tumors using multiple anti-cancer agents suspended in a lipid contrast medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Intraarterial infusion of 5-fluoro-2-deoxyuridine-C8 dissolved in a lymphographic agent in malignant liver tumors. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Choice of emergency operative procedure for bleeding duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Controlled Blocking of Hepatic Artery Flow with Enzymatically Degradable Microspheres Combined with Oncolytic Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Intra-arterial mitomycin C treatment of unresectable liver tumours. Preliminary results on the effect of degradable starch microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Phase II study of hepatic arterial degradable starch microspheres and mitomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Regional chemotherapy for colorectal hepatic metastases using degradable starch microspheres. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Major hepatic resection for metachronous metastases from colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Transcatheter arterial embolization for hepatocellular carcinoma. Benefits and limitations for unresectable cases with liver cirrhosis evaluated by comparison with other conservative treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Treatment of secondary hepatic tumours by ligation of hepatic artery and infusion of cytotoxic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Effective palliative treatment of metastatic carcinoid tumors with intra-arterial chemotherapy/chemoembolization combined with octreotide acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Regional infusion for colorectal hepatic metastases. A randomized trial comparing the hepatic artery with the portal vein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Colorectal metastases to the liver: selective chemoembolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Utility of embolization or chemoembolization as second-line treatment in patients with advanced or recurrent colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

CT findings after hepatic chemoembolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Distribution and effect of iodized poppyseed oil in the liver after hepatic artery embolization: experimental study in several animal species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

Chemoembolization for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980401%2982%3A7%3C1250%3A%3AAID-CNCR7%3E3.0.CO%3B2-J

10.1002/(SICI)1097-0142(19980401)82:7<1250::AID-CNCR7>3.0.CO;2-J

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference